Company news
Sihuan Pharmaceutical Holdings Group Ltd. news in 2020
Sihuan Pharmaceutical Holdings Group Ltd.'s news releases, calls and decks from 2020, newest first.
Voluntary announcement official release of the result of large-scale clinical trials after the launch of cinepazide maleate injection the drug takes stroke treatment into a new era with its verified efficacy
August 21, 2020
Voluntary announcement - capital injection by new investors into beijing ruiye drugs manufacture co., ltd. (an associate of Sihuan Pharmaceutical) to accelerate capacity expansion
August 19, 2020
Notice of board meeting
August 13, 2020
Voluntary announcement - acquisition of all interests and intellectual property rights of plazomicin, a new generation of aminoglycoside antibiotics in the greater china region
February 20, 2020
Voluntary announcement - production approval granted for rivastigmine hydrogen tartrate capsule, the first drug passing consistency evaluation and levetiracetam tablet and the first registration approval granted for midazolam oromucosal solution
February 18, 2020
VOLUNTARY ANNOUNCEMENT - Commencement of Phase III Clinical Trial in the PRC for Self-Developed Innovative Patented Drug "Anaprazole Sodium" and Inclusion of "Huineng" into the National Reimbursement Drug List
February 13, 2020
Voluntary announcement - Sihuan Pharmaceutical and hetero labs limited reached a framework cooperation agreement in pharmaceutical manufacturing area
February 11, 2020